相关实验视频

Updated: Jun 13, 2025

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

低剂量SAHA通过促进MHC I表达在非小细胞肺癌中来增强CD8⁺T细胞介导的抗瘤免疫力

Wenqian Dong¹, Bing He¹, Yanhong Cao²

¹Department of Laboratory Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Core Unit of National Clinical Research Center for Laboratory Medicine, Hefei, Anhui, China.

Cellular oncology (Dordrecht, Netherlands)

|September 16, 2024

概括

低剂量的酸 (SAHA) 增强了非小细胞肺癌 (NSCLC) 细胞中主要基因相容性复合物I (MHC I) 的表达. 这增强了CD8+T细胞介导的抗瘤免疫力,为NSCLC提供了一种新的免疫疗法策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

非小细胞肺癌 (NSCLC) 是一种侵袭性癌症,对传统治疗的反应有限.
瘤免疫逃脱通常涉及MHC I表达的下调.
MHC I上调的潜力改善NSCLC免疫疗法尚未被探索.

研究的目的:

为了研究低剂量的酸甲基酸 (SAHA) 是否可以通过上调MHC I表达来增强NSCLC的抗瘤免疫力.
阐明SAHA对MHC I表达和T细胞活性影响的潜在分子机制.

主要方法:

利用流式细胞计,qPCR和西部斑块分析SAHA治疗后NSCLC细胞中的MHC I,STAT1和Smad2/3表达.
通过西部斑点和免疫光学研究化STAT1和Smad2/3的核转移.
雇员搜索数据库和ChIP-qPCR以确定STAT1和Smad2/3上调的机制.
在SAHA治疗中评估了CD8+T细胞的体内和体外抗瘤作用.

主要成果:

低剂量SAHA可提高NSCLC细胞中MHC I表达的调节,而不会影响细胞活力.
在SAHA诱导的MHC I上调促进了小鼠模型中的CD8+T细胞激活,增殖和细胞毒性.
从机制上讲,SAHA抑制了HDAC,增加了STAT1,Smad2和Smad3基因促进器中的H3K9ac和H3K27ac,导致STAT1,Smad2/3的表达升高.
化STAT1和Smad2/3核转位显著增加了MHC I表达.

结论:

低剂量SAHA通过上调MHC I表达来增强NSCLC中CD8+T细胞介导的抗瘤免疫力.
揭示了SAHA介导免疫增强的关键机制.
为NSCLC治疗提供了一种新的免疫疗法策略.

关键词:

反瘤免疫力抗瘤免疫力在 MHC I 中.在NSCLCLC中,我们可以看到.萨哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈美国国家统计局 (STAT1)斯马德2/3 在线观看

更多相关视频

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.